CN Patent

CN106132398A — 免疫球蛋白的雾化

Assigned to CSL Behring AG · Expires 2016-11-16 · 10y expired

What this patent protects

本发明涉及通过包括多克隆免疫球蛋白(Ig)的组合物的雾化产生气雾剂的方法。有效的膜雾化器的选择以及针对使用这样的膜雾化器雾化而优化的组合物形成了特别有效的产生用于将Ig给药于呼吸道的气雾剂的方法。

USPTO Abstract

本发明涉及通过包括多克隆免疫球蛋白(Ig)的组合物的雾化产生气雾剂的方法。有效的膜雾化器的选择以及针对使用这样的膜雾化器雾化而优化的组合物形成了特别有效的产生用于将Ig给药于呼吸道的气雾剂的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN106132398A
Jurisdiction
CN
Classification
—
Expires
2016-11-16
Drug substance claim
No
Drug product claim
No
Assignee
CSL Behring AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.